内射人妻无码色AV天堂,BAOYU最新无码网站在线观看,亚洲AV无码一区二区三区网站,欧洲女人牲交视频免费
<span id="ryzno"></span>
<object id="ryzno"></object>
<th id="ryzno"></th>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2021.12.11
關(guān)于向全資子公司天道醫(yī)藥（香港）有限公司增資的公告
2021.12.11
關(guān)于延長(zhǎng)員工持股計(jì)劃存續(xù)期的公告
2021.12.11
關(guān)于為面向?qū)I(yè)投資者公開(kāi)發(fā)行公司債券增加增信措施并 提供反擔(dān)保的公告
2021.12.11
第五屆董事會(huì)第十五次會(huì)議決議公告
2021.12.11
第五屆監(jiān)事會(huì)第八次會(huì)議決議公告
2021.12.02
第五屆董事會(huì)第十四次會(huì)議決議公告
2021.11.26
關(guān)于參加2021深圳轄區(qū)“溝通傳遞價(jià)值，交流創(chuàng)造良好 生態(tài)”上市公司投資者網(wǎng)上集體接待日...
2021.11.09
聯(lián)合資信評(píng)估股份有限公司關(guān)于終止“16海普瑞”信用等級(jí)的公告
2021.11.03
深圳市海普瑞藥業(yè)集團(tuán)股份有限公司 “16海普瑞”本息兌付及摘牌公告
2021.10.28
H股公告
第一頁(yè)
上一頁(yè)
18
19
20
21
22
下一頁(yè)
最后一頁(yè)
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
